Navigation Links
The cause of all hereditary sensory and autonomic neuropathy type II cases has been established
Date:6/10/2008

A major discovery that details the existence of a neuronal specific form of the WNK1 gene, henceforth referred to as the WNK1/HSN2 isoform, was recently completed by the research group of Dr. Guy A. Rouleau and published in the scientific journal The Journal of Clinical Investigation. The group led by Dr. Rouleau is part of the University of Montreal Hospital Centre (CHUM), the CHUM Research Centre (CRCHUM) and the Sainte-Justine University Hospital Centre. Dr. Rouleau is also a professor at the University of Montreal. Their recent results will hereafter help to explain all the cases of hereditary neuropathy type II.

Hereditary sensory and autonomic neuropathy type II (HSANII) is a severe and early onset disorder that starts early during childhood. It is characterized by loss of perception to pain, touch and heat attributable to a loss of peripheral sensory nerves in the lower and upper limbs. Unfortunately no therapy is currently available for individuals suffering from hereditary neuropathy type II. In 2004, Dr. Rouleau's team identified the DNA sequence of HSN2 as encoding a novel gene but their more recent investigations have now shown that this sequence is more precisely linked to the expression of a WNK1 isoform that is exclusively detected in the nervous system. Till their discovery, the presence of mutations in WNK1 were only observed in individual suffering from a rare form of hypertension known as Gordon syndrome and no WNK1 isoform were exclusively expressed in the nervous system. The observation of mutations specific to the WNK1/HSN2 isoform in individuals with hereditary sensory and autonomic type II will henceforth allow the generation of animal models of the disease and help to better understand the implication of this gene and its mutations in the sensorial loss mentioned above.

Despite the severity of the symptoms observed in hereditary sensory and autonomic neuropathy type II, this important discovery points to the rol
'/>"/>

Contact: Nathalie Forgue
nathalie.forgue.chum@ssss.gouv.qc.ca
514-801-5762
University of Montreal
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Drug for cluster headaches may cause heart problems
2. Study Points to Cause of Vioxx Heart Risk
3. Damp, Moldy Homes May Cause Depression
4. Constipations Many Causes and Cures
5. High Co-Pays Cause Seniors to Go Without Meds
6. 13 percent of women stop taking breast cancer drug because of side effects, U-M study finds
7. Vocal cord dysfunction may be caused by work
8. Study finds drug spending caps cause some seniors to quit taking key medicines
9. Medicare Spending Caps Cause Seniors to Stop Meds
10. Gene Mutations May Cause Rare Neonatal Diabetes
11. Patent Expiries of Proscar and Flomax/Harnal Will Cause a Significant Decline in Near-Term Sales of Benign Prostatic Hyperplasia Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... By Amanda Gardner HealthDay Reporter , , ... colonoscopies frequently complain about having the procedure, which ... detect precancerous or cancerous growths. But a ... colonoscopy to the less invasive and less time-consuming ... been the standard of care for colon cancer ...
(Date:5/23/2012)... the United Kingdom have determined that azithromycin, a ... be an effective treatment option for patients suffering ... that occurs in the majority of patients following ... cause of mortality after the first year following ... repeatedly rejects the transplanted lung tissue. The syndrome ...
(Date:5/22/2012)... -- Children born with cleft lip, cleft palate ... beyond appearance. , Patients can face serious airway, ... social and psychological challenges, Laura Swibel Rosenthal, MD, ... in the June 2012 issue of Otolaryngologic ... of patients with craniofacial syndromes is complex," Rosenthal ...
(Date:5/22/2012)... -- Researchers at Barrow Neurological Institute at St. ... and why the public perceives some magic tricks ... in military tactics, marketing and sports. , Susana ... and Stephen Macknik, PhD, of Barrow,s Laboratory of ... into magic and illusions. Their most recent original ...
(Date:5/22/2012)... Richmond, Va. (May 22, 2012) Scientists ... be one step closer to developing a new ... that the targeted agents obatoclax and sorafenib kill ... when the drugs are administered individually., Recently published ... study led by Steven Grant, M.D., Shirley Carter ...
Breaking Medicine News(10 mins):Health News:Patients Prefer More Invasive Form of Colon Scan: Study 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 3Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Cleft lip/palate cause much more than cosmetic problems 2Health News:Barrow researchers use magic for discoveries 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3
... firm Anapol, Schwartz, Weiss, Cohan, Feldman and Smalley, P.C., was ... Justice,s (AAJ) executive committee at the organization,s recent annual convention ... ... August 20, 2008 -- http://www.anapolschwartz.com/attorneys/sol_weiss.shtml?ID=toplintrack20081111 [Sol H. Weiss], ...
... Aug. 20 Peer-reviewed safety and ... Stimulation (eToims(R)),successfully applied to patients suffering ... August/September issue of Electromyography and,Clinical Neurophysiology. ... associated physicians Jennifer Chu, M.D. and ...
... Inc. (Nasdaq:,EVVV) today announced that Pat Spangler, chief financial ... present at the Morgan,Stanley Global Healthcare Unplugged Conference at ... the Grand Hyatt New York located at 109 East,42nd ... To access the webcast, go to the investors, ...
... 19 The United States Agency,for International Development (USAID) is ... aid to help the millions of people in need,of assistance ... of,split yellow peas, 6,150 MT of vegetable oil, 6,320 MT ... is only one of multiple strategies USAID,is implementing to alleviate ...
... Offering Enhanced Customer Service ... ... ModernMed, http://www.ModernMed.com, announced its partnership with Dr. Neil ... patients with primary care focused on prevention and aging well.,Enhanced ...
... Sunrise Senior Living,Inc. (NYSE: SRZ ) announced today ... board of directors effective August 18. Glyn Aeppel, board,member ... Hotels and David Fuente, director and former chairman and ... class of directors whose,term of office expires at Sunrise,s ...
Other Medicine News:Health News:Anapol Schwartz Attorney Named to Executive Committee of American Association for Justice 2Health News:Positive Findings Published on Emergent Technology for Treating Chronic Pain 2Health News:USAID Expedites Emergency Food Aid to Horn of Africa 2Health News:ModernMed Announces Partnership With Dr. Neil J. Sapin, M.D. 2Health News:Sunrise Senior Living Appoints Glyn Aeppel and David Fuente to its Board 2
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... Delcath Systems, Inc. (Nasdaq: DCTH ) today announced the ... Dr. Contag is a proven corporate executive with extensive experience ... , (LOGO: http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO ) , ... Inc. in 2006 and served as CEO. Prior to starting ...
... & Alzheimer,s Disease , , ... today announced that its researchers have uncovered a new ... a potential target for developing novel therapeutics for intervention ... Institute,s Pancham Bakshi, Ph.D., is detailed in the ...
Other Medicine Technology:Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 2Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 3Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 2Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 3
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: